ORIC Pharmaceuticals Inc. (ORIC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
10.43
0.52 (5.25%)
At close: Jan 15, 2025, 11:49 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 23.38M | 66.84M | 226.01M | 78.45M | 89.16M | 42.64M | 25.82M |
Short-Term Investments | 184.80M | 139.43M | 10.97M | 215.15M | n/a | n/a | n/a |
Long-Term Investments | 26.85M | 21.95M | 43.39M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 552.00K | 11.52M | 12.32M | 319.00K | 1.85M | 496.00K | 513.00K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.41M | 4.18M | 7.09M | 6.19M | 840.00K | 1.09M | 791.00K |
Total Current Assets | 212.60M | 210.46M | 240.52M | 296.70M | 90.00M | 43.72M | 26.61M |
Property-Plant & Equipment | 12.01M | 3.25M | 2.41M | 1.98M | 2.24M | 2.51M | 2.90M |
Goodwill & Intangibles | n/a | -3.18M | -3.41M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 39.41M | 36.72M | 58.12M | 2.30M | 4.09M | 3.01M | 3.41M |
Total Assets | 252.01M | 247.18M | 298.64M | 299.00M | 94.09M | 46.73M | 30.02M |
Account Payables | 944.00K | 1.32M | 1.89M | 757.00K | 152.00K | 446.00K | 940.00K |
Deferred Revenue | n/a | n/a | n/a | 546.00K | 495.00K | 438.00K | 388.00K |
Short-Term Debt | 2.75M | 2.66M | 1.93M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 16.76M | 11.41M | 11.34M | 8.24M | 4.71M | 1.71M | 1.28M |
Total Current Liabilities | 20.46M | 15.39M | 15.15M | 9.00M | 5.35M | 2.60M | 2.61M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 7.46M | 9.44M | 10.52M | 219.00K | n/a | 107.31M | n/a |
Total Long-Term Liabilities | 7.46M | 9.44M | 10.52M | 219.00K | 765.00K | 108.56M | 1.69M |
Total Liabilities | 27.92M | 24.83M | 25.67M | 9.22M | 6.12M | 111.16M | 4.30M |
Total Debt | 10.21M | 2.66M | 1.93M | n/a | n/a | n/a | n/a |
Common Stock | 6.00K | 5.00K | 4.00K | 4.00K | 2.00K | 1K | 1K |
Retained Earnings | -434.93M | -334.23M | -245.11M | -166.39M | -92.69M | -65.81M | -44.44M |
Comprehensive Income | 258.00K | -1.29M | -103.00K | -31.00K | -178.06M | -2.58M | 0.00 |
Shareholders Equity | 224.09M | 222.35M | 272.98M | 289.78M | 87.97M | -64.43M | 25.73M |
Total Investments | 211.66M | 161.38M | 54.36M | 215.15M | n/a | n/a | n/a |